相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03A-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial
Stephane Heijmans et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine Among Pregnant Women: Lowered Antibody Response by Prior Seasonal Vaccination
Satoko Ohfuji et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
Karl G. Nicholson et al.
LANCET INFECTIOUS DISEASES (2011)
Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial
Shingo Uno et al.
MICROBIOLOGY AND IMMUNOLOGY (2011)
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
Nick J. Andrews et al.
VACCINE (2011)
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
J. Garcia-Sicilia et al.
VACCINE (2011)
Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy Older Adults
Ru-Chien Chi et al.
CLINICAL INFECTIOUS DISEASES (2010)
AS03A-Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
Francois Roman et al.
CLINICAL INFECTIOUS DISEASES (2010)
A Single Dose of Unadjuvanted Novel 2009 H1N1 Vaccine Is Immunogenic and Well Tolerated in Young and Elderly Adults
Kawsar R. Talaat et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
Eric Plennevaux et al.
LANCET (2010)
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
Xiao-Feng Liang et al.
LANCET (2010)
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers
Abdullah S. Madhun et al.
VACCINE (2010)
Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial
Francois Roman et al.
VACCINE (2010)
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
Isabel Leroux-Roels et al.
VACCINE (2010)
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
Alfonso Carmona et al.
VACCINE (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Claire S. Waddington et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine.
Michael E. Greenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Novel Influenza A (H1N1) Vaccine in Various Age Groups.
Feng-Cai Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults
Daniel Wai-Sing Chu et al.
VACCINE (2009)
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
Tino F. Schwarz et al.
VACCINE (2009)
Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses
Renata J. M. Engler et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
分享论文
